Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. OS Therapies NYSE:OSTX$1.93 +0.05 (+2.66%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$2.00 +0.07 (+3.83%) As of 06:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS TherapiesMarket Capitalization$54.23 millionP/E Ratio-2.24Consensus RatingBuyConsensus Price Target$18.00 (+832.6% Upside)Volume162,417 sharesAverage Volume457,571 shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Western Copper & Gold NYSE:WRN$1.25 0.00 (0.00%) As of 07/1/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$250.01 millionP/E Ratio-62.50Consensus RatingBuyConsensus Price Target$4.00 (+220.0% Upside)Volume271,005 sharesAverage Volume370,437 shares3. Reviva Pharmaceuticals NASDAQ:RVPH$0.37 -0.01 (-3.07%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.37 +0.00 (+1.25%) As of 06:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$18.29 millionP/E Ratio-0.47Consensus RatingBuyConsensus Price Target$9.00 (+2,336.4% Upside)Volume2.05 million sharesAverage Volume1.32 million shares4. GeoVax Labs NASDAQ:GOVX$0.48 -0.38 (-43.98%) As of 07/1/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$13.79 millionP/E Ratio-0.13Consensus RatingBuyConsensus Price Target$11.10 (+2,188.7% Upside)Volume15.89 million sharesAverage Volume1.57 million shares5. Quince Therapeutics NASDAQ:QNCX$1.52 -0.13 (-7.88%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.60 +0.08 (+4.93%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$75.02 millionP/E Ratio-1.09Consensus RatingBuyConsensus Price Target$8.00 (+426.3% Upside)Volume267,043 sharesAverage Volume305,223 shares6. Denison Mine NYSEAMERICAN:DNN$1.75 -0.07 (-3.85%) Closing price 07/1/2025 04:10 PM EasternExtended Trading$1.75 0.00 (0.00%) As of 05:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MineMarket Capitalization$1.63 billionP/E Ratio-21.88Consensus RatingBuyConsensus Price Target$3.00 (+71.4% Upside)Volume64.42 million sharesAverage Volume49.26 million shares7. Immunic NASDAQ:IMUX$0.69 -0.01 (-1.02%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.70 +0.01 (+2.11%) As of 06:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$66.83 millionP/E Ratio-0.56Consensus RatingBuyConsensus Price Target$11.60 (+1,580.2% Upside)Volume962,473 sharesAverage Volume961,956 shares8. Lucid Diagnostics NASDAQ:LUCD$1.10 -0.05 (-4.35%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.10 0.00 (0.00%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$124.42 millionP/E Ratio-0.82Consensus RatingBuyConsensus Price Target$3.55 (+222.7% Upside)Volume1.37 million sharesAverage Volume653,953 shares9. FibroBiologics NASDAQ:FBLG$0.60 -0.02 (-3.47%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.60 +0.00 (+0.07%) As of 06:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$23.81 millionP/E Ratio-2.86Consensus RatingBuyConsensus Price Target$13.00 (+2,064.5% Upside)Volume662,166 sharesAverage Volume299,661 shares10. Ovid Therapeutics NASDAQ:OVID$0.32 -0.01 (-4.21%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.32 +0.00 (+0.63%) As of 06:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$23.46 millionP/E Ratio-0.90Consensus RatingBuyConsensus Price Target$3.13 (+888.9% Upside)Volume1.36 million sharesAverage Volume433,434 shares11. Stardust Power NASDAQ:SDST$0.19 0.00 (-1.27%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.19 0.00 (-0.26%) As of 06:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$11.85 millionP/E Ratio-0.26Consensus RatingBuyConsensus Price Target$5.11 (+2,528.5% Upside)Volume1.97 million sharesAverage Volume712,869 shares12. Ur Energy NYSEAMERICAN:URG$1.05 0.00 (0.00%) Closing price 07/1/2025 04:10 PM EasternExtended Trading$1.06 +0.01 (+0.86%) As of 04:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$383.06 millionP/E Ratio-8.08Consensus RatingBuyConsensus Price Target$2.30 (+119.0% Upside)Volume4.02 million sharesAverage Volume4.62 million shares13. Nuvation Bio NYSE:NUVB$1.94 -0.02 (-0.77%) Closing price 07/1/2025 03:59 PM EasternExtended Trading$1.98 +0.05 (+2.38%) As of 06:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation BioMarket Capitalization$663.51 millionP/E Ratio-0.82Consensus RatingBuyConsensus Price Target$7.17 (+270.4% Upside)Volume6.07 million sharesAverage Volume2.92 million shares14. United States Antimony NYSE:UAMY$1.97 -0.21 (-9.63%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.99 +0.02 (+0.96%) As of 06:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States AntimonyMarket Capitalization$234.63 millionP/E Ratio-49.25Consensus RatingBuyConsensus Price Target$3.38 (+71.3% Upside)Volume7.91 million sharesAverage Volume2.67 million shares15. Biomea Fusion NASDAQ:BMEA$1.72 -0.08 (-4.44%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.74 +0.02 (+0.87%) As of 06:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$67.63 millionP/E Ratio-0.48Consensus RatingBuyConsensus Price Target$21.40 (+1,144.2% Upside)Volume2.20 million sharesAverage Volume1.15 million shares16. Gain Therapeutics NASDAQ:GANX$1.57 -0.23 (-12.78%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.56 -0.01 (-0.32%) As of 04:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$53.90 millionP/E Ratio-1.83Consensus RatingBuyConsensus Price Target$8.20 (+422.3% Upside)Volume599,742 sharesAverage Volume294,704 shares17. Context Therapeutics NASDAQ:CNTX$0.63 -0.03 (-4.23%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.64 +0.01 (+1.83%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$58.77 millionP/E Ratio-2.02Consensus RatingBuyConsensus Price Target$5.50 (+776.5% Upside)Volume190,117 sharesAverage Volume271,383 shares18. Zura Bio NASDAQ:ZURA$1.05 0.00 (0.00%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.04 -0.01 (-0.57%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. More about Zura BioMarket Capitalization$71.79 millionP/E Ratio-1.50Consensus RatingBuyConsensus Price Target$14.33 (+1,265.1% Upside)Volume585,195 sharesAverage Volume461,535 shares19. Nkarta NASDAQ:NKTX$1.71 +0.05 (+3.01%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.74 +0.03 (+1.46%) As of 06:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$117.79 millionP/E Ratio-1.13Consensus RatingBuyConsensus Price Target$14.33 (+738.2% Upside)Volume364,666 sharesAverage Volume1.03 million shares20. Aclaris Therapeutics NASDAQ:ACRS$1.41 -0.01 (-0.70%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.46 +0.05 (+3.55%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$153.76 millionP/E Ratio-1.01Consensus RatingBuyConsensus Price Target$9.71 (+589.0% Upside)Volume715,066 sharesAverage Volume1.20 million shares21. Erasca NASDAQ:ERAS$1.36 +0.09 (+7.09%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.34 -0.02 (-1.10%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Erasca, Inc, a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. More about ErascaMarket Capitalization$359.77 millionP/E Ratio-2.19Consensus RatingBuyConsensus Price Target$4.57 (+236.1% Upside)Volume1.23 million sharesAverage Volume1.66 million shares22. Acrivon Therapeutics NASDAQ:ACRV$1.23 +0.04 (+3.36%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.23 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Acrivon Therapeutics, Inc, a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. More about Acrivon TherapeuticsMarket Capitalization$37.31 millionP/E Ratio-0.55Consensus RatingBuyConsensus Price Target$17.71 (+1,340.2% Upside)Volume396,134 sharesAverage Volume265,376 shares23. Bitfarms NASDAQ:BITF$0.84 +0.00 (+0.48%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.88 +0.03 (+3.77%) As of 06:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. More about BitfarmsMarket Capitalization$467.12 millionP/E Ratio-4.44Consensus RatingBuyConsensus Price Target$4.44 (+425.6% Upside)Volume17.07 million sharesAverage Volume27.28 million shares24. InflaRx NASDAQ:IFRX$0.80 +0.01 (+1.27%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.80 0.00 (-0.13%) As of 07/1/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRxMarket Capitalization$53.03 millionP/E Ratio-0.98Consensus RatingBuyConsensus Price Target$6.60 (+725.0% Upside)Volume190,447 sharesAverage Volume288,984 shares25. Tenaya Therapeutics NASDAQ:TNYA$0.60 -0.01 (-1.34%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$0.62 +0.02 (+2.99%) As of 06:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$99.42 millionP/E Ratio-0.52Consensus RatingBuyConsensus Price Target$6.25 (+936.5% Upside)Volume1.05 million sharesAverage Volume2.69 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
